Acute hemodynamic effects of alpha human atrial natriuretic polypeptide in patients with congestive heart failure.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Japanese Heart Journal

• Publication date

  1988-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1536/IHJ.29.143PMID 2969428
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Potentiation of nitroglycerin-induced coronary dilatation by N-acetylcysteine.

  1986cited by this paper
• Molecular forms of atrial natriuretic polypeptides in mammalian tissues and plasma.

  1985cited by this paper
• The effects of human atrial 28-amino acid peptide on systemic and renal hemodynamics in anesthetized rats.

  1985cited by this paper
• Hemodynamic effects of α-human atrial natriuretic polypeptide (α-HANP) in rats

  1985cited by this paper
• Vasodilatory and diuretic actions of α-human atrial natriuretic polypeptide (α-hANP)

  1985cited by this paper
• Vasodilator profile of synthetic atrial natriuretic factor.

  1984cited by this paper
• Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP)

  1984cited by this paper
• Elevated plasma catecholamines in hypertensives with primary glomerular diseases.

  1983cited by this paper

• Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes

  2013cites this paper
• Efficacy and safety of short‐term administration of recombinant human atrial natriuretic peptide (rhANP) for congestive heart failure: a phase II, multicentre randomized controlled dose‐finding study

  2013cites this paper
• Atrial natriuretic peptide and regulation of vascular function in hypertension and heart failure: implications for novel therapeutic strategies.

  2013cites this paper
• Acute efficacy of low-dose human atrial natriuretic peptide monotherapy without loop diuretics for acute decompensated heart failure with left ventricular systolic dysfunction: a case report.

  2010cites this paper
• Systolic Blood Pressure at Admission as a Predictor of the Response to Initial Carperitide Therapy in Patients Hospitalized for Acute Decompensated Heart Failure with Left Ventricular Systolic Dysfunction

  2009cites this paper
• In vivo Dilatation of the Postnatal Ductus Arteriosus by Atrial Natriuretic Peptide in the Rat

  2007cites this paper
• Multicenter prospective investigation on efficacy and safety of carperitide for acute heart failure in the 'real world' of therapy.

  2005cites this paper
• Effects of Exogenous and Endogenous Natriuretic Peptides on Forearm Vascular Function in Chronic Heart Failure

  2004cites this paper
• Endocrine and paracrine aspects of vascular control : the effects of natriuretic peptides on human capacitance in health and chronic heart failure

  2004cites this paper
• Modulation of the natriuretic peptide system in heart failure: from bench to bedside?

  2003cites this paper
• Usefulness of carperitide for the treatment of refractory heart failure due to severe acute myocardial infarction.

  2001cites this paper
• Atrial natriuretic factor in chronic heart failure.

  1991cites this paper
• ANP Infusion in the Treatment of Heart Failure and Comparison with ACE Inhibition

  1990cites this paper
• Effects of UK 69 578: a novel atriopeptidase inhibitor.

  1989cites this paper
• Harnessing the therapeutic potential of atrial natriuretic peptide

  1989cites this paper
• Effects of alpha human atrial natriuretic polypeptide on the systemic hemodynamics and coronary circulation in patients with ischemic heart disease.

  1988cites this paper